A Study of GFH312 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication (IC)
Clinical trial NCT05618691 · WITHDRAWN
Trial details
- NCT number
- NCT05618691
- Sponsor
- Zhejiang Genfleet Therapeutics Co., Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2023-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.